24 Apr UK Dermal Fillers Market To Be Valued US$ 80.0 Mn by 2023, Wider Acceptance and Popularity Among Young Generation Driving The Market Revenue Growth
Analyst Speak: UK Dermal Fillers Market
“The UK Dermal Fillers Market poised to reach US$ 80.0 Mn by 2023 with CAGR of 8.2% over six years forecast period 2018-2023 owing to growing demand for non-surgical aesthetic treatments”
Precision Business Insights (PBI) in its report titled “UK Dermal Fillers Market: Market Estimation, Dynamics, Segment Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023” assesses the market performance over six years forecast period. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
The UK Dermal Fillers market was valued around US$ 50.0 Mn in 2017 and projected to reach US$ 80.0 Mn by 2023 owing to wider products availability, growing adoption dermal fillers by healthcare fraternity, and inherent benefits of dermal fillers. According to a survey conducted by Whatclinic.com there was 24% increase in the inquiries about the dermal fillers from only 2015 to 2016. Furthermore, procedures are gaining traction due to its affordability and non-invasiveness. According to The British Association of Aesthetic Plastic Surgeons (BAAPS), the number of British citizens undergoing cosmetic surgery fell in 2016 to the lowest number in a decade, while non-surgical cosmetic treatments continue to rise.
UK Dermal Fillers market segmented on the basis of product type, ingredient type, application, and distribution channel
Hyaluronic acid dermal fillers accounted for larger revenue share in UK dermal fillers market
Based on ingredient type UK dermal fillers market segmented into Hyaluronic Acid (HLA), Poly-L-Lactic Acid (PLA), Calcium Hydroxylapatite (CaH), Polymethylmethacrylate (PMMA), and Collagen dermal fillers. Hyaluronic acid dermal fillers accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to its biocompatible nature and wider product availability in the market. However, Polymethylmethacrylate dermal fillers segment projected exhibit lowest growth rate compared with other dermal fillers, which is mainly attributed to its long-term adverse effects.
Distributors influence on customer product choice
PBI interviewed several distributors/wholesalers and aesthetic practitioners to understand the buying behavior and ascertain the critical factors influencing purchasing decision. Several distributors are found to be offering products at discounted prices to lure the customers. Moreover, distributors offering free products upon the bulk purchase ranging from 50 – 100 boxes depending on the value and volume of the product. Several distributors noted that they suggest cheaper alternative to the current products to assist the customers in purchasing decision. New services offered by distributors helping them to gain the large customers and assisting in wide product offerings to the prescribers. For Instance, DigitRx, Digital prescription services by church pharmacy. DigitRx! Specifically designed for medical professionals in the aesthetic industry, the system makes ordering online fast, easy and convenient.
Key players profiled in the UK dermal fillers market report include Galderma S.A, Merz Pharma, Allergan plc., ADODERM GmbH, Teoxane SA, Sinclair Pharma plc., and HA-DERMA
By Product Type
- Absorbable Dermal Fillers
- Non-Absorbable Dermal Fillers
By Ingredient Type
- Hyaluronic Acid (HLA)
- Poly-L-Lactic Acid (PLA)
- Calcium Hydroxylapatite (CaH)
- Polymethylmethacrylate (PMMA)
- Aesthetic Restoration
- Wrinkle Reduction
- Reconstructive Surgery
By Distribution Channel
- Retail Pharmacies
- Beauty/Aesthetic Clinics
- Online Pharmacies